Driving Innovation in the Biotech Sector: Insights from Kiran Mazumdar-Shaw

Thursday, 12 September 2024, 03:33

Biocon Chairperson Kiran Mazumdar-Shaw emphasized the critical need for innovation in the biotech sector during Global Bio-India 2024. She called for increased investment in research and development, highlighting how innovation can drive value creation in the industry. With India's strengths in biosciences and technology, she envisions a future where genetic diseases may be cured through advancements like CRISPR technologies. This shift towards a culture of intellectual property is vital for India's growth in the global pharmaceutical landscape.
Indiatimes
Driving Innovation in the Biotech Sector: Insights from Kiran Mazumdar-Shaw

Innovation-Driven Value Creation in Biotech

During the Global Bio-India 2024 event, Biocon Chairperson Kiran Mazumdar-Shaw addressed the critical need for more investment in research and development to foster innovation within India’s biotech sector. She asserted that innovation is essential for driving value creation in biotechnology, which is pivotal for India to capture greater market share in the global pharmaceutical landscape.

India's Role in Global Biotech

Mazumdar-Shaw pointed out that India, already the world's largest exporter of generics and a key player in vaccine production, ranks 14th in value within the global pharma market. She stressed the importance of enhancing research and development efforts to nurture a strong culture of intellectual property.

  • CRISPR and Genetic Advancements: The advent of CRISPR technologies presents unprecedented opportunities in healthcare, enabling potential cures for genetic conditions like cystic fibrosis.
  • VIGYAN Dhara Initiative: This Rs 10,000 crore initiative is aimed at boosting basic research and critical technologies in biotechnology.
  • Biotechnology for Food Security: She highlighted the substantial role biotech plays in ensuring global food security.

India's Biopharmaceutical Manufacturing

Reflecting on India's strengths, Kiran stated, “One in three pills consumed in the U.S. and one in four in the U.K. are produced in India.” This statistic underscores India's significant contribution to global medicine production.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe